Located within the University Hospital of Liege (CHU, Belgium), Artialis occupies offices and laboratories on more than 400m2. The dedicated laboratories are separated into 4 distinct areas for R&D, histology, ELISA kits production, and biomarker testing.
Thanks to its exclusive partnership with ATC pharma, Artialis has access to an early phase hospital-based unit. Our clinical offer includes creative and innovative study design for first-in-human, proof of concept, drug interaction, and single ascending dose/multiple ascending dose (SAD/MAD) trials, allowing for shortened timelines and quicker go/no-go decisions.
Thanks to our partnership with the CER Groupe, we have dedicated premises within the Novalis Science Park (Belgium). These facilities offer a high level of quality to the customers, in an environment meeting the highest certification criteria.